CSL welcomes new treatment for high-risk cardiovascular disease to the PBS

October 7, 2024 Latest News BioPharma News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

CSL Seqirus has welcomed the recent PBS listing of VAZKEPA (icosapent ethyl) for statin-treated patients with elevated triglycerides and at high risk of heart attack and stroke. …

Subscribe now to continue reading.

Latest Video

‘Trojan Horse’ treatment offers hope for Australians facing relapsed multiple myeloma
November 24, 2025 - Latest News
New national report warns of deepening ovarian cancer burden and calls for urgent action
November 24, 2025 - Latest News
A scrapped website, almost $100 million, and the politics of what really matters
November 23, 2025 - Latest News
NSW Premier opens Australia’s first large-scale health translation hub at UNSW
November 24, 2025 - Latest News
New review recommends a balanced and measured approach to adopting AI in clinical practice
November 24, 2025 - BioPharma

CSL welcomes new treatment for high-risk cardiovascular disease to the PBS

This is a preview of subscriber content

Latest Video

Most Read

‘Trojan Horse’ treatment offers hope for Australians facing relapsed multiple myeloma

New national report warns of deepening ovarian cancer burden and calls for urgent action

A scrapped website, almost $100 million, and the politics of what really matters

NSW Premier opens Australia’s first large-scale health translation hub at UNSW

New review recommends a balanced and measured approach to adopting AI in clinical practice

New Stories

Scorecard reveals Australia is still ignoring its deadliest and most costly cancer

Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science

Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high

Australia has 'all the ingredients' but has to decide what kind of health system it wants

Report calls for Type 1 diabetes screening with 25,000 unknowingly living with early disease

New report shows precision approach extends lives but many still missing out

AusBiotech appoints Anthea Stephenson to lead national industry growth program

Sign In

CSL welcomes new treatment for high-risk cardiovascular disease to the PBS

This is a preview of subscriber content

Latest Video

Most Read

‘Trojan Horse’ treatment offers hope for Australians facing relapsed multiple myeloma

New national report warns of deepening ovarian cancer burden and calls for urgent action

A scrapped website, almost $100 million, and the politics of what really matters

NSW Premier opens Australia’s first large-scale health translation hub at UNSW

New review recommends a balanced and measured approach to adopting AI in clinical practice

Follow Us

New Stories

Scorecard reveals Australia is still ignoring its deadliest and most costly cancer

Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science

Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high

Australia has 'all the ingredients' but has to decide what kind of health system it wants

Report calls for Type 1 diabetes screening with 25,000 unknowingly living with early disease

New report shows precision approach extends lives but many still missing out

AusBiotech appoints Anthea Stephenson to lead national industry growth program